All
Results: 35245-35256 of 67206

Genethon and Hansa Biopharma announce initiation of a Phase 2 trial of imlifidase as a pre-treatment to GNT-0003 in severe Crigler-Najjar syndrome

Configit's CLM-as-a-Service Lays the Foundation for the Next Generation of Configuration Lifecycle Management






